- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/81 - AmidesImides
Patent holdings for IPC class C07D 213/81
Total number of patents in this class: 1334
10-year publication summary
|
121
|
90
|
115
|
80
|
79
|
83
|
60
|
77
|
51
|
35
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Akebia Therapeutics, Inc. | 115 |
42 |
| Corteva Agriscience LLC | 2692 |
38 |
| Syngenta Participations AG | 1790 |
33 |
| Novartis AG | 10709 |
32 |
| Syngenta Crop Protection AG | 6192 |
30 |
| F. Hoffmann-La Roche AG | 7947 |
23 |
| Hoffmann-La Roche Inc. | 3484 |
20 |
| Theravance Biopharma R&D IP, LLC | 456 |
17 |
| Bristol-myers Squibb Company | 4850 |
16 |
| Merck Patent GmbH | 5773 |
14 |
| Purdue Pharma L.P. | 502 |
14 |
| Centre National de La Recherche Scientifique | 10576 |
13 |
| Sumitomo Chemical Company, Limited | 9086 |
12 |
| Bayer Pharma AG | 1054 |
10 |
| Takeda Pharmaceutical Company Limited | 2706 |
10 |
| Vertex Pharmaceuticals Incorporated | 1626 |
10 |
| Institut Curie | 600 |
10 |
| Genentech, Inc. | 4012 |
9 |
| Boehringer Ingelheim International GmbH | 4648 |
9 |
| Dow AgroSciences LLC | 1222 |
9 |
| Other owners | 963 |